SCHEDULE 13D

ALAUNOS THERAPEUTICS INC

Common stock · CUSIP: 98973P309

Event date: 2025-10-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Chris Butterworth

  Shares: 10,700.00 · Class: 0.5%

• Richard Jones

  Shares: 16,000.00 · Class: 0.7%

• Edward Jones

  Shares: 11,750.00 · Class: 0.5%

• Gareth Downing

  Shares: 19,552.00 · Class: 0.9%

• Richard Kotey

  Shares: 12,530.00 · Class: 0.6%

• Chris Cole

  Shares: 15,856.00 · Class: 0.7%

• Arif Chaudrey

  Shares: 6,423.00 · Class: 0.3%

• Emma Babb

  Shares: 10,366.00 · Class: 0.5%

• Colin Craig

  Shares: 7,000.00 · Class: 0.3%

• John Nicholls

  Shares: 16,743.00 · Class: 0.8%

• Carl Ware

  Shares: 1,721.00 · Class: 0.1%

• Andrew Turner

  Shares: 13,035.00 · Class: 0.6%

• Matthew Robbins

  Shares: 10,036.00 · Class: 0.5%

• Phillip James Stead

  Shares: 11,012.00 · Class: 0.5%

• Stephen Hennessy

  Shares: 7,108.00 · Class: 0.3%

• Greg Arnold

  Shares: 10,735.00 · Class: 0.5%

• Michelle Douglas

  Shares: 8,494.00 · Class: 0.4%

• Price AdrianReported CIK 0002094682

  Shares: 189,061.00 · Class: 8.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.